Ibuprofen-induced inhibition of cyclooxygenase isoform gene expression and regression of rat mammary carcinomas

Fredika M. Robertson, Michelle L. Parrett, Farahnaz S. Joarder, Mary Ross, Hussein M. Abou-Issa, Galal Alshafie, Randall E. Harris

Research output: Contribution to journalArticlepeer-review

82 Scopus citations

Abstract

A single dose of 75 mg/kg 7,12 dimethylbenz[a]anthracene was administered to 50-day-old virgin female Sprague-Dawley rats and 100 days later, animals were randomized and provided with Teklad rodent chow mixed with a dose of 25 mg/rat/day ibuprofen for 35 days. Ibuprofen treatment reduced tumor volume (P < 0.05) and significantly inhibited gene expression of both cyclooxygenase-1 and cyclooxygenase-2 (P < 0.02). These results indicate that ibuprofen induced significant regression of established mammary carcinomas which was associated with inhibition of expression of isoforms of the gene responsible for prostaglandin production.

Original languageEnglish (US)
Pages (from-to)165-175
Number of pages11
JournalCancer Letters
Volume122
Issue number1-2
DOIs
StatePublished - Jan 9 1998
Externally publishedYes

Keywords

  • COX
  • Ibuprofen
  • Mammary carcinoma
  • NSAIDs
  • Prostaglandin G/H synthase

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint

Dive into the research topics of 'Ibuprofen-induced inhibition of cyclooxygenase isoform gene expression and regression of rat mammary carcinomas'. Together they form a unique fingerprint.

Cite this